CLRB vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

CLRB

42.3
AI Score
VS
CBIO Wins

CBIO

45.7
AI Score

Investment Advisor Scores

CLRB

42score
Recommendation
HOLD

CBIO

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLRB CBIO Winner
Net Income -5.65M 153,942 CBIO
Operating Income -5.79M -152.63M CLRB
ROE -169.5% 0.1% CBIO
ROA -50.8% 0.1% CBIO
Total Assets 11.12M 240.29M CBIO
Cash 8.35M 213.19M CBIO
Current Ratio 1.90 6.56 CBIO
Free Cash Flow -4.85M -72.45M CLRB

Relative Price Performance (Last 90 Days)

CLRB 1M: -5.3% · 3M: -1.1% CBIO 1M: -13.0% · 3M: -17.7%

Current Technical Phase

CLRB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.4 · Price: $2.66

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $14.87

Fundamentals Snapshot

Metric CLRB CBIO
Market Cap
Forward P/E -1.5 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 1.0%
Operating Margin 0.0% -14.3%
EPS -5.38 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.